Literature DB >> 1960305

Clinicopathologic description of myocarditis.

E B Lieberman1, G M Hutchins, A Herskowitz, N R Rose, K L Baughman.   

Abstract

Histologic evidence of myocarditis was demonstrated in 35 of 348 patients submitted to endomyocardial biopsy over 5 years. Analysis of the histologic findings and clinical course of these patients resulted in a new clinicopathologic classification of myocarditis in which four distinct subgroups are identified. Patients with fulminant myocarditis become acutely ill after a distinct viral prodrome, have severe cardiovascular compromise, multiple foci of active myocarditis by histologic study and ventricular dysfunction that either resolves spontaneously or results in death. Patients with acute, chronic active and chronic persistent myocarditis have a less distinct onset of illness. Patients with acute myocarditis present with established ventricular dysfunction and may respond to immunosuppressive therapy or their condition may progress to dilated cardiomyopathy. Those with chronic active myocarditis initially respond to immunosuppressive therapy, but they have clinical and histologic relapses and develop ventricular dysfunction associated with chronic inflammatory changes including giant cells on histologic study. Chronic persistent myocarditis is characterized by a persistent histologic infiltrate, often with foci of myocyte necrosis but without ventricular dysfunction despite other cardiovascular symptoms such as chest pain or palpitation.

Entities:  

Mesh:

Year:  1991        PMID: 1960305     DOI: 10.1016/0735-1097(91)90493-s

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  54 in total

Review 1.  Influence of myocarditis on left ventricular function.

Authors:  K L Baughman
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Myocarditis, pericarditis and other pericardial diseases.

Authors:  C M Oakley
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

3.  Secondary and Infiltrative Cardiomyopathies.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

4.  Correlation between clinical presentation and delayed-enhancement MRI pattern in myocarditis.

Authors:  L Natale; A De Vita; C Baldari; A Meduri; M Pieroni; A Lombardo; F Crea; L Bonomo
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

Review 5.  Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients.

Authors:  Matteo Pozzi; Carlo Banfi; Daniel Grinberg; Catherine Koffel; Karim Bendjelid; Jacques Robin; Raphaël Giraud; Jean François Obadia
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up.

Authors:  J R Sharma; S Sathanandam; S P Rao; S Acharya; V Flood
Journal:  Pediatr Cardiol       Date:  2008-03       Impact factor: 1.655

Review 7.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Successful heart transplantation following neonatal necrotic enterovirus myocarditis.

Authors:  Jacob Simmonds; David Cubitt; Michael Ashworth; Michael Burch
Journal:  Pediatr Cardiol       Date:  2007-12-25       Impact factor: 1.655

9.  New perspectives of infections in cardiovascular disease.

Authors:  Ignatius W Fong
Journal:  Curr Cardiol Rev       Date:  2009-05

Review 10.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.